Global Tigecycline Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Tigecycline Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
Tigecycline report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tigecycline market is projected to reach US$ 4635.8 million in 2034, increasing from US$ 1445.3 million in 2022, with the CAGR of 17.9% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
Global Tigecycline Sales Channel is wide, like Hospital Pharmacies , Retail Pharmacies. Hospital Pharmacies is the largest consumer channel.
Tigecycline can be mainly divided into Generic Drug, Original Drug.
In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tigecycline market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
Segment by Type
Original Drug
Generic Drug
Hospital Pharmacies
Retail Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tigecycline market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tigecycline, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tigecycline industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tigecycline in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tigecycline introduction, etc. Tigecycline Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Tigecycline market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Tigecycline report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tigecycline market is projected to reach US$ 4635.8 million in 2034, increasing from US$ 1445.3 million in 2022, with the CAGR of 17.9% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
Global Tigecycline Sales Channel is wide, like Hospital Pharmacies , Retail Pharmacies. Hospital Pharmacies is the largest consumer channel.
Tigecycline can be mainly divided into Generic Drug, Original Drug.
In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tigecycline market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tigecycline market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tigecycline, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tigecycline industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tigecycline in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tigecycline introduction, etc. Tigecycline Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Tigecycline market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.